South Dakota Zantac lawyers claim cancer of stomach, bladder, pancreas, liver, & esophagus.
South Dakota Zantac Lawyers for Cancer Claims
Sioux Falls · Rapid City
Call Now: (888) 510-9256
Hotline Open 24 Hours
Our South Dakota Zantac lawyers represent antacid patients diagnosed with certain cancers. South Dakota Zantac lawsuits claim the drug manufacturer failed to warn of risks of gastric, esophageal, liver, bladder & pancreatic cancer.
As such, South Dakota Zantac patients diagnosed with these cancers may be eligible for a cash settlement.
Stomach Cancer · Esophageal · Liver · Bladder · Pancreatic Cancer
Our team of attorneys have represented thousands of victims of dangerous pharmaceutical drugs. In doing so, we have recovered millions of dollars in settlement funds on their behalf.
However, we only pursue Zantac compensation from the drug manufacturers and their affiliates, and do not file claims against our clients’ doctors or hospitals.
No Legal Fee Unless You Obtain a Settlement
While compensation may be available to qualified Zantac claimants, victims are urged to act promptly. The No. 1 claim that South Dakota Zantac victims can make for cancer compensation is one that is filed within the Statute of Limitations time period. Click here for the latest information on the Zantac multi-district litigation.
Our South Dakota Zantac cancer lawyers are available to review claims now. We offer a free case evaluation to confirm usage of Zantac and diagnosis of a qualified cancer. Further, we never charge a legal fee unless a financial recovery is obtained for our client.
Contact our South Dakota Zantac lawyers today.
South Dakota Zantac Lawsuits to Claim Cancer Settlement
In recent years, South Dakota Zantac lawyers have steered a significant legal battle involving Zantac (ranitidine), a popular over-the-counter and prescription medication used to treat heartburn and other gastrointestinal conditions.
South Dakota Zantac lawsuits allege long-term use is linked to increased risk of gastric/stomach, esophageal, liver, bladder, and pancreatic cancer. Class action style lawsuits claim the manufacturer failed to warn patients about these associated risks. Accordingly, the courts have seen a surge in settlement claims filed by SD Zantac patients diagnosed with such cancers.
SD Zantac Settlement Claims for 5 Cancers
- Stomach / Gastric Cancer
- Bladder Cancer
- Pancreatic Cancer
- Esophageal Cancer
- Liver Cancer
South Dakota Zantac Cancer Lawyer Cites Scientific Research & Reports
The controversy surrounding Zantac primarily revolves around the presence of N-Nitrosodimethylamine (NDMA), a probable human carcinogen. South Dakota Zantac stomach cancer lawyers cite studies indicating that NDMA can form from ranitidine under certain conditions, including during the digestive process. The levels of NDMA found in some ranitidine products have raised significant concerns, as prolonged exposure to high levels of this compound has been linked to an increased risk of gastric cancer and other digestive tract cancers.
Valisure’s 2019 Testing Connects Zantac Use to Esophageal Cancer
South Dakota Zantac esophageal cancer lawsuits rely on a 2019 study conducted by the online pharmacy Valisure. The comprehensive testing performed by Valisure on various ranitidine products delivered alarming results. Valisure detected extremely high levels of NDMA in every ranitidine product tested, including Zantac, far exceeding the FDA’s acceptable daily intake. They immediately alerted the FDA and requested a recall of ranitidine products. Valisure’s report started a wave of settlement claims across South Dakota by lawyers seeking compensation for esophageal cancer, bladder cancer, and more.
FDA’s Statement on NDMA Liver Cancer & Action on Zantac
Following Valisure’s report, the U.S. Food and Drug Administration (FDA) conducted its own investigation. In April 2020, the FDA announced that it found unacceptable levels of NDMA in several ranitidine products and requested the immediate removal of these products from the market. South Dakota Zantac liver cancer lawyers claim these elevated NDMA levels explain antacid patients’ illness. Further, the FDA’s report underscores numerous other potential health risks associated with long-term exposure to NDMA. Click here to view the FDA removal warning.
Sloan Kettering Study Links Zantac to Bladder & Stomach Cancer
Researchers at the Memorial Sloan Kettering Cancer Center conducted a study published in 2020, examining the link between ranitidine use and cancer. They found a statistically significant association between prolonged ranitidine use and an increased risk of bladder and stomach cancers. This study provided compelling evidence for South Dakota Zantac bladder & stomach cancer lawsuits as to the potential carcinogenic effects of ranitidine when used over a long period.
International Agency for Research on Cancer (IARC) Classifies Pancreatic Cancer
The International Agency for Research on Cancer, part of the World Health Organization, classified NDMA as a probable human carcinogen based on studies that showed an increased risk of cancer in animals exposed to NDMA. South Dakota Zantac pancreatic cancer lawyers claim this research supports lawsuit settlements. The IARC’s classification has added to the concerns about ranitidine’s safety globally, given the high levels of NDMA found in Zantac.
Regulatory Response in South Dakota Supports Zantac Cancer Victims
The findings from these major studies and reports have led to a significant reevaluation of Zantac’s safety, culminating in its removal from the market. Patients who have used Zantac for extended periods should consult with healthcare providers to discuss alternative treatments and assess any potential health risks. If a cancer diagnosis is received, antacid patients can consult with a South Dakota Zantac lawyer about filing a settlement claim.
The legal claims against Zantac manufacturers focus on several key allegations:
- Failure to Warn: South Dakota Zantac plaintiffs claim that the manufacturers knew or should have known about the risk of NDMA formation and its carcinogenic potential but failed to adequately warn consumers and healthcare providers.
- Negligence in Manufacturing: Some South Dakota Zantac lawsuits claim that the process used to manufacture ranitidine resulted in the formation of NDMA and cancer, accusing the manufacturers of negligence for not using safer alternatives.
- Misrepresentation of Safety: South Dakota Zantac lawyers also claim that the manufacturers misrepresented the drug’s safety, marketing it as a safe medication without disclosing the risks of NDMA-associated cancer.
Types of Cancer Linked to Zantac
South Dakota lawsuits have brought attention to the potential link between Zantac and several types of cancer:
- Gastric Cancer: Given ranitidine’s use in treating stomach conditions, the alleged link to stomach cancer is particularly concerning. SD lawyers argue that the NDMA in Zantac can cause mutations leading to gastric cancer.
- Esophageal Cancer: Esophageal cancer claims focus on the proximity of the esophagus to the stomach, suggesting that exposure to NDMA from ranitidine could increase the risk of cancer in this area.
- Liver Cancer: The liver’s role in metabolizing substances can make it vulnerable to carcinogens like NDMA, leading to SD lawsuit claims that Zantac use is linked to an increased risk of liver cancer.
- Bladder Cancer: NDMA is excreted through the urine, raising concerns that it could cause bladder cancer in individuals using Zantac.
- Pancreatic Cancer: Pancreatic cancer, one of the most lethal forms of cancer, is also claimed by SD plaintiffs alleging that NDMA exposure from Zantac use could contribute to the development of this disease.
We file Zantac cancer lawsuits in the State of South Dakota and across the United States.
- Sioux Falls, SD
- Rapid City, SD
- Aberdeen, SD
- Brookings, SD
- Watertown, SD
- Mitchell, SD
- Yankton, SD
- Pierre, SD
- Huron, SD
- Spearfish, SD
- Vermillion, SD
- Box Elder, SD
- Brandon, SD
Contact our South Dakota Zantac lawyers today for a free case review.